708
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

The use of experimental design in the optimization of risperidone biodegradable nanoparticles: in vitro and in vivo study

, , &
Pages 313-320 | Received 01 Jan 2016, Accepted 25 Jan 2016, Published online: 21 Feb 2016
 

Abstract

The aim of this study was optimization of risperidone (model drug) biodegradable nanoparticles utilizing emulsion–solvent evaporation technique. Box–Behnken design was adopted to optimize the preparation process. Optimized nanoparticles were characterized for surface morphology using scanning electron microscope. Pharmacokinetic parameters were compared with the marketed tablets. Results revealed that the optimized formula showed 297.37 nm, 85.12%, and 59.79% for Y1, Y2, and Y3, respectively. Optimized formula showed significant improved bioavailability compared with marketed tablets. Successful achievement of prolonged risperidone release with improved bioavailability is expected to maximize patients’ adherence to their antipsychotic drug therapy and to minimize risk of relapse during maintenance therapy.

Acknowledgements

The authors would like to thank Dr K M El-Say (Faculty of Pharmacy, King Abdulaziz University) for useful discussions of the experimental design work.

Disclosure statement

The authors report no conflicts of interest in this work.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.